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Abstract 
BACKGROUND AND AIM: An important goal of periodontal plastic surgery is the creation of attached gingiva around the 
teeth. In this study, the aims were to culture gingival fibroblasts in a biodegradable scaffold and measure the width of 
attached gingiva after the clinical procedure. 
METHODS: This study was carried out on 4 patients (8 sites), with inadequate attached gingiva next to at least two teeth 
in contralateral quadrants of the same jaw. A biopsy of attached gingiva (epithelial + connective tissue) was taken using 
a surgical blade. Following culture of gingival fibroblasts, 250 × 10
3
 cells in 250 µl nutritional medium were mixed 
with platelet-rich in growth factor (PRGF). Periosteal fenestration technique was done on one side (control) and tissue-
engineered mucosal graft (test) was carried out on the contralateral side in each patient. The width of keratinized tissue, 
probing depth (PD) and width of attached gingiva were recorded at baseline and 3 months after the operation. 
RESULTS: An increased width of keratinized and attached tissue on all operated sites after 3 months was observed. 
These results showed the increased mean of the width of keratinized and attached gingiva to be 4.17 mm and 4.14 mm 
in test and 1.10 mm and 1.10 mm in control sites, respectively. The difference of keratinized and attached gingiva width 
between test and control sites was significant (P = 0.030, and P = 0.010 respectively). 
CONCLUSION: According to the results of this study, PRGF can be used as a scaffold to transfer gingival fibroblasts to 
recipient sites with significant clinical results. 
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n important goal of periodontal 
plastic surgery is the regeneration of 
attached gingiva.1 Several surgery 
techniques such as denudation,2 
periosteal retentions,3 periosteal fenestration,4,5 
apically positioned flap,6 connective tissue 
grafts,7 free gingival grafts,8 and acellular 
dermal matrix allografts9 were proposed to 
increase the attached gingiva. At the present 
time, connective tissue and free gingival grafts 
are usually used to augment the gingiva, 
because of the predictability of these 
procedures. However, some disadvantages are 
existed about masticatory mucosal grafts such 
as postoperative pain at the donor site, 
morbidity, reducing the size of a donor site, 
formation of exocytosis, poor color matching 
to the surrounding tissue, and increased 
A 
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procedure duration.9-11 Therefore, a technique 
with fewer disadvantages is preferred by the 
patients and clinicians. Tissue engineering 
technology is already being developed and 
applied in different medical fields to replace 
cartilage, bone, cardiovascular components, 
pancreas, and skin.12 According to this fact, 
tissue engineering could also be useful in 
periodontology. Cells, scaffolds and growth 
factors are the three principal components for 
preparation of a tissue-engineered construct.12 
Epithelial cells and fibroblasts are used to 
develop the tissue engineered gingival grafts 
(TEGG).13-21 Benzyl ester hyaluronic acid, 
collagen, polyglactin mesh, and chitosan are 
the scaffolds used in periodontology aiming at 
gingival augmentation.15,19,20,22 
Platelet-rich plasma (PRP) is an 
autogenous concentration of platelets in 
which platelet counts should be 5 times more 
than the baseline number of platelets in 
whole blood.23 PRP has been used clinically 
in human since the 1970s for its healing 
properties.24 PRP is also called plasma rich in 
growth factors (PRGF), platelet concentrates 
(PCs), and autologous platelet gel (APG).25 
Platelet activation in PRP results in releasing 
of growth factors such as platelet-derived 
growth factor (PDGF), vascular endothelial 
growth factor (VEGF), transforming growth 
factor-β (TGF-β), and insulin-like growth 
factor (IGF).25 All of which are proven 
beneficial to wound healing.26 PRP as a 
biogenic scaffold for tissue engineering have 
not been applied in the reconstruction of the 
oral mucosa. We used PRP as a scaffold in 
tissue engineering, because of the safety, low 
preparation cost, and existence of fibrin and 
growth factors in it.26 
The aim of our research was to culture the 
human gingival fibroblasts in PRGF as a 
scaffold and investigate its influence on 
gingival augmentation. 
Methods 
This study was a pilot randomized controlled 
clinical trial. Four woman patients (8 sites), 
aged 32 to 46 years, with less than enough 
attached gingiva surrounding at least two 
teeth in contralateral quadrants of the same 
jaw were included in this study. They were 
selected from the patients referred to 
Department of Periodontology of Kerman 
Dental School, Iran. 
Inclusion criteria in this study were no 
pregnancy and lactation, no medication 
affecting on periodontium, no smoking, no 
periodontal diseases, no systemic diseases 
affecting on periodontium or 
contraindicating periodontal surgery, full 
mouth plaque index and full mouth bleeding 
index < 20% at the time of surgery. 
Explanation regarding the aim and course 
of the study was given to patients and 
informed consent was obtained. This study 
was ethically approved by Ethics Committee 
of Kerman School of Medical and Dental 
Sciences, Iran. Kerman University approved 
the consent form and design of the present 
study with ethical code 96/86/K. This clinical 
trial was registered in IRCT website with 
number IRCT201108135305N2. 
Clinical measurements: At baseline and  
3 months after surgery, probing depth (PD), 
the width of keratinized and attached gingiva 
were measured and recorded. Williams’s 
periodontal probe was used to measure the 
width of keratinized gingiva from the 
gingival margin to the mucogingival junction 
to the nearest millimeter. Roll test was used 
for detection of mucogingival junction. The 
PD was subtracted from the width of 
keratinized gingiva, and the width of 
attached gingiva was specified in the mid-
buccal region for each involved teeth. One 
clinician who was blind to this study 
measured all of the clinical parameters at 
baseline and 3 months after surgery and also 
allocated surgery sites. Another clinician who 
was not blind to the study performed all of 
the surgical procedures. 
Biopsy and cell culturing: At the first visit, 
a biopsy (~ 3 × 2 × 1 mm) was taken from a 
site with adequate attached gingiva under 
local anesthesia. The gingival biopsy 
(connective tissue and epithelium) in a 
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nutritional medium [Roswell Park Memorial 
Institute (RPMI) 1640], (Gibco, Paisley, 
Scotland, UK) containing antibiotics [penicillin 
(Sigma- Aldrich, USA), 100 IU/ml, and 
streptomycin (Sigma- Aldrich, USA), 100 
µg/ml] was sent to the laboratory. The 
patients were required to use chlorhexidine 
digluconate 0.2% mouthwash for several days. 
Each gingival biopsy was washed three 
times in phosphate buffered saline (PBS) 
(Sigma- Aldrich, USA), and then transferred 
to a Petri dish. A scalpel was used to cut each 
sample into small pieces under sterile 
conditions. These pieces in a petri dish 
containing 0.25% trypsin (Sigma- Aldrich, 
USA) were incubated at 37 °C, 5% CO2 for 1 
hour. After incubation, the gingival 
epithelium was separated from the gingival 
connective tissue and washed with PBS. A 
solution of 80 µl/ml type I collagenase 
(Sigma- Aldrich, USA) was added to digest 
the gingival connective tissue pieces in order 
to obtain gingival fibroblasts. After one night 
incubation, RPMI 1640 was added to the Petri 
dish and the suspension was centrifuged for 
5 minutes to eliminate the collagenase 
enzyme. The fibroblasts were cultured in 
nutritional medium (RPMI 1640) containing 
10% fetal bovine serum (FBS) (Gibco, Paisley, 
Scotland, UK), and antibiotics (penicillin  
100 IU/ml and streptomycin 100 µg/ml). The 
cells were cultured in a CO2 incubator at  
37 °C and the nutritional medium was 
changed twice a week. When the culture 
reached 80-90% confluence for fibroblasts, 
trypsin-EDTA was used to detach the cells 
for 5 minutes. Then, detached fibroblasts 
were used to produce tissue engineered 
gingival graft (TEGG). 
Preparation of TEGG: PRGF was used as a 
scaffold for production of TEGG. For the 
preparation of PRGF, 10 ml blood was taken 
from the patients. The blood was poured into 
two 5 ml tubes containing trisodium citrate 
3.8% (BTI, Vitoria, Spain) and was centrifuged 
at 2600 rpm for 5 minutes. 0.5 ml of plasma 
which was in the red blood cell (RBC) layer 
(PRGF) in each of the tubes was gathered with 
a micropipettor. 1 ml PRGF was poured into a 
5 ml Petri dish. For activation of platelets in 
PRGF and neutralization of the effect of 
trisodium citrate, 50 µl 10% calcium chloride 
(BTI, Vitoria, Spain) was added. Then,  
250 × 103 cells in 250 µl RPMI 1640 medium 
(count with hemocytometer) was added to 
PRGF. In order to set initially, it was put 
under the hood at room temperature for  
10 minutes. After that, the TEGG was 
incubated for 30 minutes. After incubation, 
nutritional medium RPMI 1640 was added 
and incubated overnight to use in the clinic. 
Before transferring the graft to the clinic, it 
was rinsed with PBS several times (Figure 1). 
It was transferred to the dental clinic in a 
sterile situation, filled with RPMI 1640, and 
sealed with parafilm. 
 
 
Figure 1. Plasma rich in growth factors (PRGF) 
containing the patient's cultured fibroblasts after 
24 hours 
 
Surgery and postoperative instructions: In 
this study, control (no graft) and test (TEGG) 
sites were selected randomly by a coin toss in 
each patient (simple randomization). The 
recipient bed preparation in control and test 
sites was the same. In order to prepare the 
recipient bed, after a local anesthesia with 
lidocaine 2% and epinephrine 1/80000, the 
mucogingival junction was horizontally 
incised (a submarginal incision) and two 
vertical releasing incisions were created 
apically for ~ 10 mm. The length of horizontal 
incision was about 15 mm. The bed was 
prepared by sharp dissection with a scalpel. 
Then, a periosteal fenestration was done about 
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7 mm apical to the horizontal incision. At the 
control site, on the partial thickness prepared 
bed, a gauze and aluminum foil in an 
appropriate size were placed on the bed, 
respectively. These components were 
stabilized with a 4-0 silk criss-cross horizontal 
mattress suture (Figure 2).  
 
 
Figure 2. Control site A) Preoperative 
photograph, B) Periosteal fenestration technique 
is performed, C) A Vaseline gauze is placed on 
the recipient bed and a foil is adapted and fixed 
with a criss-cross horizontal mattress suture and 
D) At 3 months, tissue augmentation is obtained 
 
At the test sites, after the TEGG was cut to 
an appropriate size, it was placed on the 
partial thickness bed. Gauze and aluminum 
foils in an appropriate size were adapted on 
the surface of the graft, respectively.20 A  
4-0 silk criss-cross horizontal mattress suture 
was used to fix these components (Figure 3). 
During the first two weeks, the patients 
were asked not to use chlorhexidine 
mouthwash to prevent damage to the 
fibroblasts and discontinue toothbrush. After 
2 weeks following surgery, sutures were 
removed. After the surgery, supragingival 
tooth cleaning along with oral hygiene 
instructions were carried out once a week for 
the first 6 weeks and continued as once a 
month for up to 3 months post-surgery. 
 
 
Figure 3. Test site A) Preoperative photograph, 
B) After preparation of bed tissue-engineered 
gingival graft is adapted to the recipient area,  
C) Vaseline gauze and foil are adapted and fixed 
with a criss-cross horizontal mattress suture and 
D) At 3 months, tissue augmentation is obtained 
 
One-sample Kolmogorov-Smirnov test was 
used to check the normal distribution of data. 
Because of the abnormal distribution of the 
data, Wilcoxon signed-rank test was utilized 
to compare the results before and after the 
surgery in the control and test groups. 
Results 
The results of this study revealed that the 
healing process took place without any 
complication in both control (4 sites) and test 
(4 sites) sites.  
The data related to the probing pocket 
depth, the width of keratinized gingiva and 
width of attached gingiva at baseline and 3 
months after surgery are presented in table 1.  
 
Table 1. Baseline and post-surgery clinical parameters 
Clinical parameter 
Baseline (mm) 
(mean ± SD) 
Post-surgery (mm) 
(mean ± SD) 
P
*
 
Probing pocket depth Test 1.00 ± 0 1.00 ± 0 - 
Control 1.00 ± 0 1.00 ± 0 - 
Width of keratinized gingiva Test 0.83 ± 0.75 5.00 ± 0.63 0.001 
Control 1.50 ± 0.54 2.60 ± 1.50 0.030 
Width of attached gingiva Test  0.16 ± 0.40 4.30 ± 0.51 0.001 
Control 0.50 ± 0.54 1.60 ± 1.50 0.030 
SD: standard deviation 
*Wilcoxon signed-rank test 
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Table 2. Comparison of post-surgery clinical parameters between test and control groups 
Clinical parameter 
Post-surgery (mm) (mean ± SD) 
P
*
 
Test Control 
Probing pocket depth 1.00 ± 0 1.00 ± 0 - 
Width of keratinized gingiva 5.00 ± 0.63 2.60 ± 1.50 0.030 
Width of attached gingiva 4.30 ± 0.51 1.60 ± 1.50 0.010 
SD: standard deviation 
*Wilcoxon signed-rank test 
 
Also, the post-surgery clinical parameters 
of test and control groups are compared and 
shown in table 2. According to these results, 
mean of the increased width of keratinized 
and attached gingiva was 4.17 mm and  
4.14 mm in test and 1.10 mm and 1.10 mm in 
control sites, respectively, 3 months after 
surgery. The difference between the width of 
keratinized gingiva in test and control sites 
was significant (P = 0.030). Likewise, the 
comparison of attached gingiva width 
between control and test site was also 
statistically significant (P = 0.010) (Table 2). 
The comparison between the width of 
keratinized and attached gingiva before and 
after surgery showed a significant difference 
in both test and control groups (P = 0.001, 
and P = 0.030 respectively) (Table 1). 
Discussion 
In dentistry, the culture of epithelial cells for 
regeneration of oral soft tissue was 
performed, at the first.13,14 During the healing, 
the epithelial sheets are weak against 
mechanical trauma, and manipulation of 
them during surgery is difficult.14 Because of 
these disadvantages, culture of fibroblasts for 
preparation of tissue-engineered soft tissue 
grafts was indicated.15,16,19-21 According to the 
study carried out by Karring et al., the 
morphogenetic stimuli of the underlying 
connective tissue control the keratinization of 
gingival epithelium.27 Therefore, culture of 
the fibroblasts was performed to produce 
tissue-engineered soft tissue grafts in several 
studies.15,19,20,22 In this study, we used 
fibroblasts and an autologous scaffold 
(PRGF) to augment the gingiva. Both control 
and test sites showed a significant increase of 
keratinized and attached gingiva width,  
3 months after surgery. The average increase 
in keratinized and attached gingiva was  
4.17 mm and 4.14 mm, respectively. At 
control sites, the average increased width of 
keratinized and attached gingiva was  
1.10 mm which was statistically significant. 
The difference between the control and test 
groups in regard to the width of keratinized 
and attached gingiva was 3.06 mm and  
3.04 mm, respectively. In a study done by 
Prato et al., benzyl ester of hyaluronic acid 
was introduced as a scaffold.15 
Gingival fibroblasts were cultured and 
seeded onto this scaffold and this prepared 
tissue was grafted onto a periosteal bed. The 
average increased keratinized tissue was  
2.00 ± 0.41 mm. In this study, the keratinized 
gingiva increased about 2.17 mm more than 
aforementioned study. The difference 
between the type of scaffold and bed 
preparation (marginal incision in Prato et al. 
study and sub-marginal incision in our 
study) can explain this result. Another study 
evaluated a living human fibroblast-derived 
dermal substitute (HF-DDS) and compared it 
to a gingival autograph (GA).19 McGuire and 
Nunn used an absorbable polyglactin 
scaffold and allogeneic dermal fibroblasts. 
The average of increased keratinized gingiva 
around the teeth with inadequate attached 
gingiva was 2.72 mm after 3 months post-
surgery. In this study, although the amount 
of increased keratinized tissue was less in test 
sites, the esthetic result was better than 
control sites. 
Mohammadi et al. in a study, used a 
collagen type I (Zyderm)  as a scaffold which 
human gingival fibroblasts were seeded into 
it.20 Results showed mean increased width of 
keratinized and attached gingiva to be  
2.8 mm in test (TEGG) and 1.9 and 2 mm in 
control sites (periosteal fenestration 
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technique), respectively, 3 months after 
surgery. When test and control groups were 
compared, the width of keratinized and 
attached gingiva clinically increased (0.9 mm 
and 0.8 mm, respectively). In the present 
study, about 1.37 mm keratinized gingiva 
and 1.34 mm attached gingiva was obtained 
more than the results of Mohammadi et al.21 
study. In these two studies, bed preparation 
(periosteal fenestration), dimensions of 
recipient bed, incisions, cells (fibroblast) were 
similar. Only, the difference between the 
scaffolds can infer these results. Mohammadi 
et al. in a case report, showed that using a 
cultured gingival graft (fibroblasts + collagen 
scaffold) can increase the width of pri-
implant keratinized tissue.21 
In an animal study, chitosan was used as a 
carrier for transporting fibroblasts to the 
recipient bed prepared in the mouth of dogs, 
in order to gingival augmentation.22 At test 
sites (chitosan + fibroblasts), the width of 
keratinized gingiva showed a 2.13 mm 
increase in mid-buccal surface of teeth. At 
control sites (chitosan), the width of 
keratinized gingiva increased about 1 mm. 
The difference between test and control sites 
was not statistically significant. Scheyer et al. 
showed that application of living cellular sheet 
in the treatment of mucogingival defects 
resulted in better color, absence of scar, and 
better mucogingival junction alignment in 
comparison with free gingival graft.28 
The present study showed the most 
increased keratinized and attached gingiva 
width among the studies performed in the 
field of soft tissue engineering. The reason 
which can explain this difference is the type 
of scaffold used in this study (PRGF). As we 
know, PRGF is a combination of fibrin and 
platelets growth factors. Platelet growth 
factors existed in α-granules become 
activated after preparation of PRGF. Growth 
factors can affect angiogenesis, proliferation 
of fibroblasts, mutagenesis, extracellular 
matrix (fibronectin, glycosaminoglycan) and 
collagen synthesis which have key roles in 
regeneration of soft tissue.27 
The use of tissue-engineered gingival 
grafts has several advantages including 
requiring a small donor site, obtaining 
enough keratinized tissue, less complaint and 
discomfort emerges for patients, and being 
safe and less costly because an autologous 
scaffold is used. According to this study, 
these tissue-engineered materials effectively 
create keratinized gingiva. Of course, further 
controlled clinical trial is needed. 
Conclusion 
Results of this investigation show that the 
tissue-engineered gingival graft is able to 
generate keratinized tissue safely and with 
little complication. Our suggestions are using 
PRGF alone at control sites in the next 
studies, and increasing the sample size for 
enhancing the power of the study. 
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